Silent hypothyroidism: when symptoms go unnoticed

Internal Medicine · Endocrinology · General Medicine

Hypothyroidism is a common endocrine disorder characterised by inadequate thyroid hormone production, resulting in metabolic slowing and disturbances across multiple organ systems. Although fatigue, weight gain, cold intolerance and constipation are traditionally associated with the condition, hypothyroidism does not always present with recognisable symptoms. In some individuals, thyroid dysfunction may remain undetected for months or even years, with subtle clinical manifestations being attributed to ageing, stress, lifestyle changes or other underlying conditions.Subclinical hypothyroidism is characterised by elevated serum thyroid-stimulating hormone (TSH) concentrations despite free thyroid hormone levels remaining within the normal reference range.[1] Recognising these less apparent presentations is important because untreated thyroid dysfunction may contribute to dyslipidaemia, cardiovascular risk and reproductive complications in selected populations. For clinicians, identifying when seemingly nonspecific complaints warrant thyroid function assessment can facilitate timely diagnosis and appropriate management.Why does hypothyroidism often go unnoticed?The clinical presentation of hypothyroidism is influenced by the severity and duration of thyroid hormone deficiency, age, comorbidities and individual physiological differences. Since thyroid hormones regulate basal metabolic activity, their deficiency can produce gradual changes that may initially be difficult to distinguish from common age-related or lifestyle-associated complaints.Several subtle manifestations may be overlooked:Persistent fatigue: Reduced energy levels and excessive tiredness may be attributed to inadequate sleep, occupational stress or nutritional deficienciesUnexplained weight gain: Gradual weight gain, sometimes accompanied by difficulty losing weight, may be overlooked when dietary and physical activity patterns are considered the primary causesMood and cognitive changes: Poor concentration, forgetfulness, low mood and reduced mental alertness may occur without obvious physical manifestationsCold intolerance: Increased sensitivity to cold temperatures may develop gradually and remain unreportedSkin and hair changes: Dry skin, hair thinning, brittle nails and increased hair shedding may be mistaken for nutritional or dermatological problemsMenstrual irregularities: Heavy menstrual bleeding, irregular cycles and fertility difficulties may occasionally be associated with underlying thyroid dysfunctionIn older adults, manifestations may be particularly nonspecific, with lethargy, cognitive slowing, constipation and reduced physical activity being mistaken for normal ageing.Subclinical hypothyroidism: The clinically silent phaseSubclinical hypothyroidism is characterised biochemically by an elevated serum TSH concentration with FT4 levels remaining within the reference range. Unlike overt hypothyroidism, symptoms may be absent or mild, making laboratory evaluation particularly importantThe condition is frequently identified incidentally during investigations performed for unrelated clinical concerns, such as dyslipidaemia, menstrual disturbances or infertilityClinical parameterSubclinical hypothyroidismOvert hypothyroidismTSHElevatedElevated in primary hypothyroidismFT4Within reference rangeReducedClinical symptomsOften absent or mildMay be more prominentDiagnosisBiochemicalBiochemical, supported by clinical assessmentTreatmentIndividualised according to TSH, risk factors and clinical contextLevothyroxine is generally indicatedA TSH concentration of 4.5-10 mIU/L is commonly used to describe mild subclinical hypothyroidism, although laboratory-specific reference ranges should be considered. TSH concentrations of 10 mIU/L or higher warrant greater clinical attention because the likelihood of progression to overt hypothyroidism and associated metabolic abnormalities may be increased.The hidden metabolic consequences: Why should clinicians pay attention?Thyroid hormones influence lipid metabolism, hepatic cholesterol synthesis and the clearance of circulating lipoproteins. Consequently, reduced thyroid hormone activity may adversely affect lipid profiles, even when overt symptoms are absent.Dyslipidaemia: Increased total cholesterol and low-density lipoprotein cholesterol (LDL-C) concentrations may be observed because of reduced hepatic LDL receptor activity and impaired cholesterol clearance. Triglyceride abnormalities may also occur in some individualsCardiovascular implications: Persistent thyroid hormone deficiency may contribute to endothelial dysfunction, increased vascular resistance and adverse lipid changes. These alterations may collectively influence cardiovascular risk, particularly in individuals with pre-existing metabolic risk factorsReproductive health: Thyroid dysfunction may be associated with menstrual irregularities, ovulatory disturbances and difficulties with conception. Thyroid function assessment is therefore relevant in selected individuals presenting with unexplained reproductive concernsImportantly, the presence of dyslipidaemia should not automatically be attributed to thyroid dysfunction. A comprehensive metabolic and cardiovascular assessment remains necessary.When should clinicians consider thyroid function testing?Thyroid function testing should be considered when compatible symptoms, clinical findings or relevant risk factors are identified. Assessment is particularly important in individuals with:Persistent unexplained fatigue or weight changesUnexplained dyslipidaemia, particularly elevated LDL-CGoitre or a personal or family history of thyroid diseaseType 1 diabetes or other autoimmune disordersMenstrual irregularities or selected fertility concernsPrevious thyroid surgery, radioactive iodine treatment or neck irradiationUse of medications associated with thyroid dysfunction, such as Lithium or AmiodaroneSerum TSH is generally used as the initial investigation, followed by FT4 measurement when TSH is abnormal. Thyroid peroxidase antibodies (anti-TPO) may also be assessed when autoimmune thyroiditis is suspected or when the risk of progression is being evaluated.ConclusionSilent hypothyroidism highlights the limitations of relying exclusively on classical symptoms to identify thyroid dysfunction. Subtle changes in energy levels, weight, cognition, lipid profiles and reproductive health may provide important clinical clues, even when characteristic manifestations are absent. A targeted approach to thyroid function assessment can facilitate earlier identification, particularly in individuals with unexplained dyslipidaemia or relevant clinical risk factors. However, biochemical abnormalities should be interpreted in their clinical context, and treatment decisions should be individualised rather than based on TSH elevation alone. For clinicians, recognising what patients may not report can be just as important as identifying the symptoms they present with.[2]Reference(s):1. Yoo WS, Chung HK. Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape. Endocrinol Metab (Seoul). 2021;36(3):500-513. doi:10.3803/EnM.2021.1066. https://pmc.ncbi.nlm.nih.gov/articles/PMC8258336/2. Bauer BS, Azcoaga-Lorenzo A, Agrawal U, et al. Management strategies for patients with subclinical hypothyroidism: a protocol for an umbrella review. Syst Rev. 2021;10(1):290. Published 2021 Nov 1. doi:10.1186/s13643-021-01842-y. https://pmc.ncbi.nlm.nih.gov/articles/PMC8561963/